Birinapant – 10 mg

Brand:
Cayman
CAS:
1260251-31-7
Storage:
-20
UN-No:
Non-Hazardous - /

Birinapant is a bivalent mimetic of the Diablo homolog known as second mitochondria-derived activator of caspase (Smac). It is an antagonist of cellular inhibitor of apoptosis 1 (cIAP1, or BIRC2), cIAP2 (BIRC3), and XIAP (BIRC4), binding each at nanomolar concentrations.{34146} Birinapant causes rapid cIAP1 degradation, caspase activation, PARP cleavage, and NF-κB activation in breast cancer cells.{34146} It shows in vivo antitumor activity, inducing apoptosis in several types of cancer xenografts in mice.{34147,34148}  

 

Available on backorder

SKU: 19699 - Category:

Description

A bivalent Smac mimetic that antagonizes cIAP1, cIAP2, and XIAP at nanomolar concentrations; causes caspase activation, PARP cleavage, and NF-κB activation in breast cancer cells


Formal name: (2S,2’S)-N,N’-[(6,6′-difluoro[2,2′-bi-1H-indole]-3,3′-diyl)bis[methylene[(2R,4S)-4-hydroxy-2,1-pyrrolidinediyl][(1S)-1-ethyl-2-oxo-2,1-ethanediyl]]]bis[2-(methylamino)]-propanamide

Synonyms:  TL-32711

Molecular weight: 806.9

CAS: 1260251-31-7

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling|NF-κB Signaling||Research Area|Cancer|Transcription Factors|NF-κB||Research Area|Immunology & Inflammation